Exhibit B
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13D with
respect to the common stock, par value $0.0001 per share, of Sunesis
Pharmaceuticals, Inc., a Delaware corporation, is, and any amendment thereto
signed by each of the undersigned shall be, filed on behalf of each undersigned
pursuant to and in accordance with the provisions of 13d-1(k) under the
Securities Exchange Act of 1934, as amended.
Dated: October 6, 2005 WARBURG, XXXXXX EQUITY PARTNERS, L.P.
By: Warburg Pincus Partners LLC,
its General Partner
By: Warburg Pincus & Co.,
its Managing Member
By: /s/ Xxxxx X. Xxxxxxx
----------------------------------
Name: Xxxxx X. Xxxxxxx
Title: Partner
Dated: October 6, 2005 WARBURG PINCUS & CO.
By: /s/ Xxxxx X. Xxxxxxx
----------------------------------
Name: Xxxxx X. Xxxxxxx
Title: Partner
Dated: October 6, 2005 WARBURG PINCUS LLC
By: /s/ Xxxxx X. Xxxxxxx
----------------------------------
Name: Xxxxx X. Xxxxxxx
Title: Member
Dated: October 6, 2005 WARBURG PINCUS PARTNERS LLC
By: Warburg Pincus & Co.,
its Managing Member
By: /s/ Xxxxx X. Xxxxxxx
----------------------------------
Name: Xxxxx X. Xxxxxxx
Title: Partner